Bamifylline: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
< | <div style="float: right;"> | ||
[[File:Bamifylline.png|thumb|none|400px|This image is provided by the National Library of Medicine.]] | [[File:Bamifylline.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} |
Revision as of 21:03, 6 April 2015
WikiDoc Resources for Bamifylline |
Articles |
---|
Most recent articles on Bamifylline Most cited articles on Bamifylline |
Media |
Powerpoint slides on Bamifylline |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Bamifylline at Clinical Trials.gov Clinical Trials on Bamifylline at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Bamifylline
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Bamifylline Discussion groups on Bamifylline Patient Handouts on Bamifylline Directions to Hospitals Treating Bamifylline Risk calculators and risk factors for Bamifylline
|
Healthcare Provider Resources |
Causes & Risk Factors for Bamifylline |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Bamifylline is a drug of the xanthine chemical class which acts as a selective Adenosine receptor A1